Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
AmpliTech targets positive EBITDA in fiscal 2027 as it scales higher-margin Open RAN radio orders

AmpliTech targets positive EBITDA in fiscal 2027 as it scales higher-margin Open RAN radio orders

ReutersReuters2026/08/17 11:16
  • AmpliTech shifted its ORAN 5G strategy toward scaling higher-margin radio orders, targeting margin improvement starting in 2027.
  • Management set a goal to reach positive EBITDA in fiscal 2027, tied to revenue growth, better ORAN economics, scaling production.
  • Planning centers on converting about USD 17 million backlog into shipments, with some deliveries expected to move into 2027.
  • Commercial push broadened to additional MNO evaluations, aiming to turn carrier discussions into purchase orders.
  • Response underway to a Tier-1 telecom infrastructure RFP, viewed as a potential tens-of-millions-of-dollars opportunity if awarded.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amplitech Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038625), on August 17, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Eli Lilly (LLY.US) launches new Class 1 drug Phase III clinical trial in China

According to the Insight database, Brenipatide is the world's first GLP-1 product to initiate Phase III clinical trials for depression.

智通财经2026/08/17 12:56
Eli Lilly (LLY.US) launches new Class 1 drug Phase III clinical trial in China

Record-breaking! Ferrari (RACE.US) sells its first electric car Luce for $40 million, scarcity premium proven in the market again

The first electric car manufactured by Ferrari (RACE.US) was sold for $40 million at an auction held by Sotheby's, setting a new record for the highest price ever paid for a new car at auction.

智通财经2026/08/17 12:56
Record-breaking! Ferrari (RACE.US) sells its first electric car Luce for $40 million, scarcity premium proven in the market again

UHS completes acquisition of Talkspace

Reuters2026/08/17 12:53